Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Sanidad Militar
versión impresa ISSN 1887-8571
Resumen
YUSTE-GUTIERREZ, AM; VILLABONA-RIVAS, I; APARICIO-HERNANDEZ, RM y GARCIA-LUQUE, A. Positive assessment of drugs: from November and December of 2022 and January of 2023. Sanid. Mil. [online]. 2023, vol.79, n.1, pp.47-49. Epub 13-Nov-2023. ISSN 1887-8571. https://dx.doi.org/10.4321/s1887-857120230001000010.
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public from November 2022 to January of 2023, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.
Palabras clave : Cipaglucosidasa alfa (Pombility®); Deucravacitinib (Sotyktu®); Etranacogén dezaparvovec (Hemgenix®); SARS-COV-2 (strain B.1.351) Spike protein (Vidprevtyn beta®); Tremelimumab (Imjudo®); Tremelimumab (Tremelimumab Astra Zeneca®).